See the rest here:
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Author Archives: Fredricko
Retrophin Completes Acquisition of Orphan Technologies
View original post here:
Retrophin Completes Acquisition of Orphan Technologies
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020
Annexon Expands Classical Complement Platform into Neurodegenerative Diseases of the Brain with Initiation of Huntington’s Disease Clinical Program
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
Berkeley Lights Reports Financial Results for Third Quarter of Fiscal Year 2020
Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
See the original post here:
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
Harpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual Meeting
ERYTECH to Present at Jefferies Virtual Healthcare Conference
Originally posted here:
ERYTECH to Present at Jefferies Virtual Healthcare Conference
Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare Conference
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Read more from the original source:
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum
EXMceuticals Provides Bi-Weekly Default Status Report
Excerpt from:
EXMceuticals Provides Bi-Weekly Default Status Report